A Non-Inferiority Comparison of Fluviral Influenza Vaccine to a U.S. Licensed Inactivated Split-Virion Vaccine (Fluzone) in Adults at least 50 Years Old Living in the Community

Trial Profile

A Non-Inferiority Comparison of Fluviral Influenza Vaccine to a U.S. Licensed Inactivated Split-Virion Vaccine (Fluzone) in Adults at least 50 Years Old Living in the Community

Completed
Phase of Trial: Phase III

Latest Information Update: 24 Mar 2009

At a glance

  • Drugs GSK 1536489A; Influenza virus vaccine
  • Indications Influenza virus infections
  • Focus Pharmacodynamics
  • Sponsors ID Biomedical Corporation
  • Most Recent Events

    • 08 Dec 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top